T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Tesla
TSLA
|
+$1.78B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.56B |
| 3 |
Broadcom
AVGO
|
+$1.28B |
| 4 |
Sempra
SRE
|
+$1.16B |
| 5 |
Booking.com
BKNG
|
+$1.08B |
Top Sells
| 1 |
PayPal
PYPL
|
+$1.69B |
| 2 |
HCA Healthcare
HCA
|
+$1.11B |
| 3 |
Bank of New York Mellon
BK
|
+$960M |
| 4 |
American Tower
AMT
|
+$930M |
| 5 |
AET
Aetna Inc
AET
|
+$866M |
Sector Composition
| 1 | Healthcare | 17.09% |
| 2 | Financials | 16.21% |
| 3 | Technology | 16.18% |
| 4 | Consumer Discretionary | 13.95% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Accenture
ACN
$157B
| $592M | 0.1% |
3,869,675
+794,615
| +26% | +$122M |
|
227
GSK
GSK
$81.8B
| $588M | 0.1% |
13,256,282
-110,328
| -0.8% | -$4.89M |
|
228
DTE Energy
DTE
$28.1B
| $584M | 0.09% |
6,273,600
+1,531,185
| +32% | +$143M |
|
229
AvalonBay Communities
AVB
$27.7B
| $584M | 0.09% |
3,272,166
-27,938
| -0.8% | -$4.98M |
|
|
SRCL
230
DELISTED
Stericycle Inc
SRCL
| $575M | 0.09% |
8,461,193
+1,075,854
| +15% | +$73.1M |
|
231
Northern Trust
NTRS
$24.7B
| $575M | 0.09% |
5,754,348
-689,260
| -11% | -$68.9M |
|
232
DexCom
DXCM
$30.7B
| $573M | 0.09% |
39,954,620
+21,972,072
| +122% | +$315M |
|
|
EVHC
233
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $567M | 0.09% |
16,415,840
+1,088,417
| +7% | +$37.6M |
|
234
Regency Centers
REG
$13.3B
| $554M | 0.09% |
8,011,698
-846,357
| -10% | -$58.6M |
|
235
Cable One
CABO
$902M
| $552M | 0.09% |
785,499
+49,666
| +7% | +$34.9M |
|
236
AT&T
T
$211B
| $543M | 0.09% |
18,507,996
-575,723
| -3% | -$16.9M |
|
237
ASML
ASML
$315B
| $536M | 0.09% |
3,083,223
+503,605
| +20% | +$87.5M |
|
|
SHPG
238
DELISTED
Shire pic
SHPG
| $531M | 0.09% |
3,422,003
-407,383
| -11% | -$63.2M |
|
239
Pediatrix Medical
MD
$1.48B
| $529M | 0.09% |
9,907,689
-846,658
| -8% | -$45.2M |
|
|
CLGX
240
DELISTED
Corelogic, Inc.
CLGX
| $528M | 0.09% |
11,417,907
+77,018
| +0.7% | +$3.56M |
|
241
Coca-Cola
KO
$292B
| $527M | 0.09% |
11,491,239
-240,314
| -2% | -$11M |
|
242
Webster Financial
WBS
$10.3B
| $525M | 0.09% |
9,355,518
-203,365
| -2% | -$11.4M |
|
243
Intel
INTC
$114B
| $521M | 0.08% |
11,283,656
-288,874
| -2% | -$13.3M |
|
|
ANDV
244
DELISTED
Andeavor
ANDV
| $520M | 0.08% |
4,544,359
-880,163
| -16% | -$101M |
|
245
Adient
ADNT
$1.97B
| $519M | 0.08% |
6,600,657
-83,027
| -1% | -$6.53M |
|
246
Exelon
EXC
$43.7B
| $519M | 0.08% |
18,474,182
-24,058,143
| -57% | -$676M |
|
247
Marathon Petroleum
MPC
$55.5B
| $518M | 0.08% |
7,855,966
+895,949
| +13% | +$59.1M |
|
248
Allegion
ALLE
$14.5B
| $513M | 0.08% |
6,452,575
+25,327
| +0.4% | +$2.02M |
|
|
BLUE
249
DELISTED
bluebird bio
BLUE
| $509M | 0.08% |
220,618
+9,350
| +4% | +$21.6M |
|
250
Casey's General Stores
CASY
$19.1B
| $508M | 0.08% |
4,542,489
-2,291
| -0.1% | -$256K |
|